Disrupting Interleukin 12 Improves Microvascular Endothelial Function in Type 2 Diabetes Through ER Stress CHOP and Oxidative Stress Mechanisms
Eman Radwan,Souad Belmadani,Khalid Matrougui
DOI: https://doi.org/10.2147/DMSO.S369488
2022-08-31
Abstract:Eman Radwan, 1, 2 Souad Belmadani, 1 Khalid Matrougui 1 1 Department of Physiological Sciences, EVMS, Norfolk, VA, 23501, USA; 2 Department of Medical Biochemistry, Faculty of Medicine, Assiut University, Asyut, Egypt Correspondence: Khalid Matrougui, Department of Physiological Sciences, EVMS, Norfolk, VA, 23501, USA, Tel +1 757-446-5278, Email Purpose: Vascular endothelial dysfunction is well established in type 2 diabetes. Interleukin-12 (IL-12) and endoplasmic reticulum (ER) stress are up-regulated in type 2 diabetic patients and animal models of type 2 diabetes. However, the role and underlying mechanisms of IL-12 and the ER stress CHOP in endothelial dysfunction are not fully understood. Methods: We generated double knockout mice between db − /db − and p40IL-12 −/− mice (db − /db −p40-IL− 12-/- ) and endoplasmic (ER) stress-CHOP −/− mice (db − /db −CHOP-/- ). We performed a glucose tolerance test (GTT) to determine the effect of IL-12 and ER stress CHOP on glucose metabolism. We assessed the endothelial function and determined the phosphorylation level of eNOS, Akt, AMPK, and the expression of ER stress (CHOP, BIP), and oxidative stress (Nox2 and Nox4 and NADPH oxidase activity). Results: The results showed that GTT was improved in db-/db −p40-IL− 12-/- and db − /db −CHOP-/- suggesting IL-12 and CHOP as parts of a mechanism involved in the development of type 2 diabetes. The microvascular endothelial dysfunction in db − /db − mouse is associated with decreased phosphorylated eNOS, Akt, AMPK, and increased CHOP, BIP, Nox2, and Nox4 expressions. Interestingly, disrupting IL-12 and ER stress CHOP in db − /db − mice significantly improved endothelial function, increased survival markers expression and decreased ER and oxidative stress. Conclusion: Using a genetic approach, these findings provide evidence that IL-12 and ER stress CHOP play a significant role in microvascular endothelial dysfunction in type 2 diabetes. Keywords: type 2 diabetes, interleukin-12, ER stress, microvascular endothelial dysfunction, oxidative stress Diabetes has affected lives for thousands of years. Type 2 diabetes is a complex metabolic disease that fundamentally arises from the loss of functional pancreatic beta cell mass associated with a significant damage to the cardiovascular system. Microvascular endothelial cell dysfunction is a clinically significant problem in patients with type 2 diabetes as it causes myocardial infarction, stroke, peripheral artery disease, retinopathy, nephropathy, cardiomyopathy and delaying wound healing. 1–9 Moreover, complications of the microcirculation often lead to hypertension, which substantially aggravates the health of diabetic patients. As a result, the concomitant cardiovascular complications are mainly responsible for the high morbidity and mortality in patients with type 2 diabetes. Despite decades of extensive biomedical research in this area, current therapies neither halt nor reverse microvascular complications that occur in type 2 diabetes. Thus, there is a critical need for the identification of mechanism-based, treatable targets to improve the microvascular cell function and limit the progression of this disease. Inflammation is a key component in the pathogenesis of type 2 diabetes and cardiovascular diseases (CVD). 10 Type 2 diabetes is associated with an increase of cytokines and adipokines secretion 11–17 capable of affecting microvascular cell function and structure. 4–7 Excessive microvascular inflammation evokes endothelial dysfunction seen in patients and mimicked in animal models with type 2 diabetes. 5–9,18–21 IL-12 is a class-I helical cytokine produced mostly by macrophages, neutrophils, and dendritic cells. 22–24 It consists of a light chain (p35 subunit) and a heavy chain (p40 subunit) that both are covalently linked forming the p70 unit. 25,26 IL-12 helps in the differentiation of T helper 1 immune cells and induces the secretion of pro-inflammatory cytokines. 25 Specifically, the level of the pro-inflammatory cytokine interleukin-12 (IL-12) is increased in adolescent and adult T2D patients and could be involved in the development of insulin resistance and vascular complications such as atherosclerosis. 26–28 However, it is unknown whether the inhibition of IL-12 protects microvascular function in type 2 diabetes. Furthermore, the mechanism by which increased IL-12 might cause vascular endothelial dysfunction is still unknown. We previously reported that endoplasmic reticulum (ER) stress is -Abstract Truncated-